Paris, France

Bruno Michel Lamas


Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Paris, FR (2020)
  • Massy, FR (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bruno Michel Lamas: Innovator in Metabolic Syndrome and Inflammatory Bowel Diseases

Introduction

Bruno Michel Lamas is a notable inventor based in Paris, France. He has made significant contributions to the fields of metabolic syndrome and inflammatory bowel diseases through his innovative research and patents. With a total of 2 patents, Lamas has established himself as a key figure in medical research.

Latest Patents

Lamas's latest patents include the use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders. This invention focuses on utilizing AhR agonists or microorganisms that produce AhR agonists to address metabolic syndrome effectively. Another significant patent involves pharmaceutical compositions for preventing or treating inflammatory bowel diseases. This invention outlines methods and compositions aimed at combating these challenging health issues.

Career Highlights

Throughout his career, Bruno Michel Lamas has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Pierre et Marie Curie (Paris 6). His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Lamas has collaborated with esteemed colleagues, including Harry Sokol and Mathias Lavie-Richard. These partnerships have further enriched his research and innovation efforts.

Conclusion

Bruno Michel Lamas is a distinguished inventor whose work in metabolic syndrome and inflammatory bowel diseases has the potential to impact many lives. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…